Skip to main content

Evidence-Based Supplement Research

Evidence-Based Supplement Research

Ergothioneine and Improved Attention Span

Doses used in studies

mg/week: 75 (median 75, IQR 75–75) — 1 study

Time to effect

Median: 12.2 months · IQR 12.2 months–12.2 months · Range 12.2 months–12.2 months — Reported in 1 of 1 study

1 of 1 paper

Investigating the efficacy of ergothioneine to delay cognitive decline in mild cognitively impaired subjects: A pilot study.
- 2024-11-15
- RCT
- Journal of Alzheimer's disease : JAD 102(3)
- - Yu Fung Yau
  - Irwin K Cheah
  - Rathi Mahendran
  - Richard My Tang
  - Ru Yuan Chua
  - Rachel Es Goh
  - Lei Feng
  - Jialiang Li
  - Ee Heok Kua
  - Christopher Chen
  - Barry Halliwell
- PubMed: 39544014
- DOI: 10.1177/13872877241291253
2 Insights on
- Improved Attention Span
- High evidence
- Clinical
Subjects receiving ergothioneine demonstrated improved performance in assessment of learning ability
Effect
Beneficial
Effect size
Moderate
Dose
25 mg per capsule, taken 3 times a week for one year